Ghost Tree Capital »

Novo Nordisk A/S shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of Novo Nordisk A/S (NVO) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in Novo Nordisk A/S

Tip: Access up to 7 years of quarterly data

All positions including Novo Nordisk A/S held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novo Nordisk A/S by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $13M 110k 119.07

More positions owned by Ghost Tree Capital

Spdr Ser Tr S&p Biotech Put Option (XBI)
Biohaven Call
Sarepta Therapeutics (SRPT)
Novo-nordisk A S Adr (NVO)
Blueprint Medicines (BPMC)
Axsome Therapeutics (AXSM)
Tarsus Pharmaceuticals (TARS)
Perspective Therapeutics Com New (CATX)
Cg Oncology (CGON)
Roivant Sciences SHS (ROIV)
Vaxcyte (PCVX)
Insmed Com Par $.01 (INSM)
Viking Therapeutics (VKTX)
Syndax Pharmaceuticals (SNDX)
Janux Therapeutics (JANX)

View all positions for Ghost Tree Capital

Top funds holding Novo Nordisk A/S

Citadel Advisors
Capital Research and Management Company - Division 3
Loomis, Sayles and
Susquehanna International
FMR
Franklin Resources
Fisher Investments
Folketrygdfondet
Goldman Sachs Group
Jane Street
Fayez Sarofim & Co
Everett Harris & Co
UBS Group
State Farm Mutual Automobile Insurance Company
State Street Corporation

View all funds holding Novo Nordisk A/S